Cite
A prospective non-interventional study on the impact of transfusion burden and related iron toxicity on outcome in myelodysplastic syndromes undergoing allogeneic hematopoietic cell transplantation.
MLA
Cremers, Eline M. P., et al. “A Prospective Non-Interventional Study on the Impact of Transfusion Burden and Related Iron Toxicity on Outcome in Myelodysplastic Syndromes Undergoing Allogeneic Hematopoietic Cell Transplantation.” Leukemia & Lymphoma, vol. 60, no. 10, Oct. 2019, pp. 2404–14. EBSCOhost, https://doi.org/10.1080/10428194.2019.1594215.
APA
Cremers, E. M. P., de Witte, T., de Wreede, L., Eikema, D.-J., Koster, L., van Biezen, A., Finke, J., Socié, G., Beelen, D., Maertens, J., Nagler, A., Kobbe, G., Ziagkos, D., Itälä-Remes, M., Gedde-Dahl, T., Sierra, J., Niederwieser, D., Ljungman, P., Beguin, Y., & Ozkurt, Z. N. (2019). A prospective non-interventional study on the impact of transfusion burden and related iron toxicity on outcome in myelodysplastic syndromes undergoing allogeneic hematopoietic cell transplantation. Leukemia & Lymphoma, 60(10), 2404–2414. https://doi.org/10.1080/10428194.2019.1594215
Chicago
Cremers, Eline M.P., Theo de Witte, Liesbeth de Wreede, Diderik-Jan Eikema, Linda Koster, Anja van Biezen, Jürgen Finke, et al. 2019. “A Prospective Non-Interventional Study on the Impact of Transfusion Burden and Related Iron Toxicity on Outcome in Myelodysplastic Syndromes Undergoing Allogeneic Hematopoietic Cell Transplantation.” Leukemia & Lymphoma 60 (10): 2404–14. doi:10.1080/10428194.2019.1594215.